These findings gave us a hint that H2BC12 might be involved in the immunoregulation of gliomas, which was consistent with a previous study that DNAJC10 was correlated with immune cell infiltrations and immune checkpoint genes (Liu et al., 2022) as well as the replication factor C2 (Zhao et al., 2022). The gene discussed is H2BC12; the disease is glioma.